PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72095-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)72095-2/fulltext
Title :
PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72095-2&doi=10.1016/S1098-3015(11)72095-2
First page :
A290
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
253